Profile | GDS2987 / GI_5454111-S |
Title | Comparison of Rho kinase inhibitor and atorvastatin effects on primary cell lines |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM214810 | HMVEC_vehicle_rep1 | 51.8 | 71 |
GSM215244 | HMVEC_vehicle_rep2 | 11.2 | 29 |
GSM215253 | HMVEC_vehicle_rep3 | 27.8 | 62 |
GSM215254 | HMVEC_atorvastatin_rep1 | 46.9 | 68 |
GSM215282 | HMVEC_atorvastatin_rep3 | 12.3 | 28 |
GSM215344 | HMVEC_atorvastatin_rep2 | 16.2 | 38 |
GSM215283 | HMVEC_atorvastatin_mevalonate_rep1 | 62.3 | 69 |
GSM215284 | HMVEC_atorvastatin_mevalonate_rep2 | 50.7 | 65 |
GSM215293 | HMVEC_atorvastatin_mevalonate_rep3 | 19.6 | 31 |
GSM215294 | HMVEC_SLx2119_rep1 | 16.1 | 49 |
GSM215295 | HMVEC_SLx2119_rep2 | 27.2 | 48 |
GSM215296 | HMVEC_SLx2119_rep3 | 0.7 | 1 |
GSM215297 | PASMC_vehicle_rep1 | 19 | 29 |
GSM215298 | PASMC_vehicle_rep2 | 47.7 | 58 |
GSM215310 | PASMC_vehicle_rep3 | 15 | 24 |
GSM215311 | PASMC_atorvastatin_rep1 | ||
GSM215312 | PASMC_atorvastatin_rep2 | 51.5 | 61 |
GSM215313 | PASMC_atorvastatin_rep3 | 21.5 | 31 |
GSM215324 | PASMC_atorvastatin_mevalonate_rep1 | 13.9 | 23 |
GSM215325 | PASMC_atorvastatin_mevalonate_rep2 | ||
GSM215326 | PASMC_atorvastatin_mevalonate_rep3 | 22.5 | 36 |
GSM215327 | PASMC_SLx2119_rep1 | ||
GSM215328 | PASMC_SLx2119_rep2 | ||
GSM215329 | PASMC_SLx2119_rep3 | 4.4 | 9 |
GSM215330 | Fibroblasts_vehicle_rep1 | 106.9 | 76 |
GSM215331 | Fibroblasts_vehicle_rep2 | 92.1 | 74 |
GSM215332 | Fibroblasts_vehicle_rep3 | 100.7 | 75 |
GSM215333 | Fibroblasts_atorvastatin_rep1 | 94.4 | 75 |
GSM215334 | Fibroblasts_atorvastatin_rep2 | 101.8 | 75 |
GSM215335 | Fibroblasts_atorvastatin_rep3 | 85.3 | 73 |
GSM215336 | Fibroblasts_atorvastatin_mevalonate_rep1 | 124.2 | 77 |
GSM215337 | Fibroblasts_atorvastatin_mevalonate_rep2 | 95.2 | 75 |
GSM215338 | Fibroblasts_atorvastatin_mevalonate_rep3 | 109.8 | 76 |
GSM215339 | Fibroblasts_SLx2119_rep1 | 71 | 72 |
GSM215340 | Fibroblasts_SLx2119_rep2 | 116.7 | 77 |
GSM215341 | Fibroblasts_SLx2119_rep3 | 79.4 | 73 |